CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Seven Bridges Genomics, Inc. and Station X, Inc., announced today that they have completed the integration of their respective platforms for researchers and clinicians seeking a seamless, end-to-end solution for scalable genomic data management, storage and analysis.
The Seven Bridges Genomics (SBG) Platform provides an integrated environment to manage any next generation sequencing data analysis workflow — from raw data through compute and storage intensive data processing protocols to usable, interpretable data. GenePool, from Station X, allows researchers to securely manage, visualize, and analyze processed genomic data from one to thousands of patients and then, securely share the data and resulting knowledge with colleagues. Together, the two platforms enable customers to perform the rapid interrogation of patient-derived sequencing data, and their associated clinical and sample metadata, in a secure and interactive way.
“The Seven Bridges Platform provides an integrated environment to manage, execute and collaborate on all aspects of sequencing analysis workflows,” said Seven Bridges Genomics CEO Deniz Kural. “We are pleased to integrate with GenePool to provide our mutual customers an easy way to go from their Seven Bridges analysis to exploration with Station X.”
“GenePool was designed to accelerate the identification and validation of biomarkers that play a role in human disease and the translation of these findings into actionable results,” said Richard Goold, CEO of Station X. “Through our collaboration with Seven Bridges Genomics, we can now provide our mutual customers with a complete solution that will allow them to manage the entire process from sample to answer – with one fully integrated, cloud-based solution.”
The integrated workflow has been in pre-release testing at selected cancer genomics research laboratories and academic centers in North America. “Our customers have now processed a number of valuable and interesting datasets related to various cancers through the combined Seven Bridges / GenePool solution. They find the integrated software to be easy-to-use, robust and very informative,” said Tod Klingler, CSO of Station X.
The integrated solution is available via either Seven Bridges Genomics or Station X, each of whom will each maintain responsibility for technical support and maintenance of their respective platforms.
For more information, please visit www.sbgenomics.com or www.stationxinc.com.
About Seven Bridges Genomics
With over 100 employees in 3 locations worldwide, Seven Bridges Genomics is the leading provider of a secure, cloud-delivered platform that enables subscribers to design and execute complex next generation sequencing data analysis pipelines without the burdens of do-it-yourself command line bioinformatics. Our comprehensive and intuitive data exploration tools help you solve big data analytics problems with ease. The Seven Bridges Platform was the first of its kind to be publicly available and currently offers researchers over 300 open-source applications and custom designed tools to advance genomic analysis. For more information, please visit www.sbgenomics.com
About Station X
Station X, Inc. was founded in 2010 by leaders in the fields of genomics and computational biology. The company’s flagship product, GenePool, enables scientists and clinicians working with large-scale human genome information to manage, organize, mine and share their data sets in a scalable, secure environment. Station X is based in San Francisco and can be found online at www.stationxinc.com.
